Corixa (company)

This article is about the biotech corporation. For the style fly tying, see Fly lure. For the heteropteran bug family, see Corixidae.

Corixa

Former type	biotechnology/pharmaceutical
Successor	acquired by GlaxoSmithKline
Founded	1994 in Seattle, Washington
Defunct	March 31, 2006 (2006-03-31)
Headquarters	Seattle, Washington
Number of locations	2

Corixa was a biotechnology/pharmaceutical company based in Seattle, Washington involved in the development of immunotherapeutics to combat autoimmune diseases, infectious diseases, and cancer. It was founded in 1994. It operated a laboratory and production facility in Hamilton, Montana.

The name Corixa comes from the true bug (Insecta: Hemiptera: Heteroptera) genus Corixa (family Corixidae, Water boatman), described by Geoffroy, in 1762.

On 12 July 2005, the European pharmaceuticals giant GlaxoSmithKline completed the acquisition of Corixa. GSK had formerly made use of the Corixa's MPL (Monophosphoryl lipid A, a derivative of the lipid A molecule), an adjuvant in some of their vaccines.

On 31 March 2006, Corixa's doors closed after over 11 years in business.

External links

"Corixa Corporation - powering the immune system". Archived from the original on 2006-03-01.

Coordinates: 47°36′58″N 122°20′03″W / 47.615976°N 122.334242°W / 47.615976; -122.334242

This article is issued from Wikipedia - version of the 11/17/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.